Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients

BACKGROUND: To investigate whether the serum free thyroxine (FT4) level is a prognostic factor for the first-attack neuromyelitis optica spectrum disorders (NMOSD). METHODS: This retrospective study enrolled 109 patients with first-attack NMOSD. The Expanded Disability Status Scale (EDSS) and the re...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Neurol
Huvudupphovsmän: He, Qianyi, Li, Lifeng, Li, Yanfei, Lu, Yanhui, Wu, Kaimin, Zhang, Ruiyi, Teng, Junfang, Zhao, Jie, Jia, Yanjie
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6921452/
https://ncbi.nlm.nih.gov/pubmed/31852443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-019-1560-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk